Sandbox: malabsorption: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 26: Line 26:
|-
|-
! align="center" style="background:#DCDCDC;" |Whipple's disease
! align="center" style="background:#DCDCDC;" |Whipple's disease
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |50th
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |40-60
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +/-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +/-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
Line 35: Line 35:
* [[Ocular motility disorders|Abnormal extraocular movement]]
* [[Ocular motility disorders|Abnormal extraocular movement]]
* [[Lymphadenopathy]]
* [[Lymphadenopathy]]
* [[Pleural effusion]]
* [[Hyperpigmentation]]
* [[Hyperpigmentation]]
* Decreased breathing sound
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
Line 49: Line 49:
* [[Hepatosplenomegaly]]
* [[Hepatosplenomegaly]]
* [[Ascites]]
* [[Ascites]]
* [[Arthritis]]
* [[Pleural effusion]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Tropheryma whipplei]]
* [[Tropheryma whipplei]]
* HLA
* [[HLA-B27]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Small intestine]] [[biopsy]] for [[Tropheryma whipplei]] testing  
* [[Small intestine]] [[biopsy]] for [[Tropheryma whipplei]] testing
* [[PCR]] testing
|-
|-
! align="center" style="background:#DCDCDC;" |[[Celiac disease]]
! align="center" style="background:#DCDCDC;" |[[Celiac disease]]
Line 60: Line 61:


Adult
Adult
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +/-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +/-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +/-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +/-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
Line 69: Line 70:
* [[Tetany]]
* [[Tetany]]
* [[Mouth ulcers]]
* [[Mouth ulcers]]
* [[Dermatitis herpetiformis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ↓
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ↓
Line 82: Line 82:
* [[Hepatosplenomegaly]]
* [[Hepatosplenomegaly]]
* [[Ascites]]
* [[Ascites]]
* [[Dermatitis herpetiformis]]
* Must follow [[Gluten-free diet]]
* Must follow [[Gluten-free diet]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[HLA-DQ2]] 
* [[HLA-DQ2]]
* [[HLA-DQ8]]  
* [[HLA-DQ8]]
* Innate responses to [[wheat proteins]]
* Innate responses to [[wheat proteins]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[IgA]] endomysial antibody
* [[IgA]] endomysial antibody
* [[IgA]] tissue transglutaminase antibody
* [[IgA]] tissue transglutaminase antibody
|
|-
! align="center" style="background:#DCDCDC;" |Grain allergy
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Childhood
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Vomiting]]
* [[Abdominal distension|Abdominal distention]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Elevated [[IgE|IgE levels]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Atopic dermatitis]]
* [[Dysphagia]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Abnormal [[immune response]] to wheat [[antigens]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Measurement of grain-specific [[IgE|immunoglobulin E (IgE)]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
|-
|-
! align="center" style="background:#DCDCDC;" |[[Cystic fibrosis]]
! align="center" style="background:#DCDCDC;" |[[Cystic fibrosis]]
Line 509: Line 485:
** [[Lymphocytic]] [[colitis]] is characterized by ≥20 intraepithelial [[lymphocytes]] (IEL) per 100 surface epithelial cells
** [[Lymphocytic]] [[colitis]] is characterized by ≥20 intraepithelial [[lymphocytes]] (IEL) per 100 surface epithelial cells
|
|
|-
! align="center" style="background:#DCDCDC;" |Grain allergy
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Childhood
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Vomiting]]
* [[Abdominal distension]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Elevated [[IgE]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Atopic dermatitis]]
* [[Dysphagia]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Abnormal [[immune response]] to wheat [[antigens]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Measurement of grain-specific [[IgE|immunoglobulin E (IgE)]]
|}
|}
</small>
</small>

Revision as of 19:11, 7 November 2017

Abbreviations: WBC: White blood cells; Plt: Platelets, Hgb: Hemoglobin, IgE: Immunoglobulin E, IgA: Immunoglobulin A

Cause Peak age of onset History Physical exam Lab findings Additional findings Cause/Pathogenesis Gold standard diagnosis
Fever Abdominal pain Diarrhea Weight loss
Watery Fatty WBC Hgb Plt Other lab findings
Whipple's disease 40-60 +/- + + + + ↓/↑
Celiac disease Childhood

Adult

- + +/- +/- + - -
  • IgA endomysial antibody
  • Anti-tissue transglutaminase antibody
  • Anti-gliadin antibody
  • IgA endomysial antibody
  • IgA tissue transglutaminase antibody
Cystic fibrosis Infancy and childhood - + + +
  • Positive DNA analysis for CFTR multimutation method
  • Evaluated nasal transepithelial potential difference (NPD)
Lactose intolerance Adult + - - +
  • Stool osmotic gap of >125 mOsm/kg 
  • Stool pH <6 
Crohns disease Young adults

(20th)

+ - + +
  • Abnormal immune response to self antigens
Laxative overuse After childhood + - +/- +/- -
Hyperthyroidism Any age + - + +/-
  • Elevated T4
  • Elevated T3
  • Decreased level of TSH
Irritable bowel syndrome Between 30 and 50 + - - + -
VIPoma Between 30 and 50 + - + +/-
  • Primary secretory tumor
  • Elevated VIP levels
  • Followed by imaging
Gastrinoma (Zollinger-Ellison syndrome) Between the ages of 20 and 50 + - + +
  • Elevated basal or stimulated serum gastrin more than 1000 pg/mL
Lactose intolerance Any age - + + +/-
Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES) Infancy + - +/- + Stool examination:
  • Triggered by cow milk protein
  • Profuse, repetitive vomiting
  • Oral food challenge (OFC)
Eosinophilic gastroenteritis  30th + - +/- +
Primary bile acid malabsorption Childhood Adolescents + +/- + +/- -
Abetalipoproteinemia Infancy - + + +
Microscopic colitis 60th + - + +
Grain allergy Childhood - + + - +